Ke Shen, Cheng Xi-Yu, Zhang Jie-Ying, Jia Wen-Jing, Li Hao, Luo Hui-Fang, Ge Peng-He, Liu Ze-Min, Wang Hong-Mei, He Jin-Sheng, Chen Zhi-Nan
College of Life Sciences and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, 100044, People's Republic of China.
State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences, Beijing, 100012, People's Republic of China.
BMC Public Health. 2015 Jul 14;15:656. doi: 10.1186/s12889-015-2021-x.
Itai-itai disease primarily results from cadmium (Cd) exposure and is known as one of the four major pollution diseases in Japan. Cd pollution is more serious in several areas of China than in Japan. However, there is still a lack of information regarding the threshold level of Cd exposure for the adverse health effects in the general Chinese population. This study aims to evaluate the reference value of urinary Cd (UCd) for renal dysfunction in a Chinese population as the benchmark dose lower confidence limit (BMDL) based on a large sample survey.
A total of 6103 participants who lived in five Cd polluted areas of China participated in this study. We analyzed UCd levels as a biomarker of exposure and urinary β2-microglobulin (Uβ2-MG) levels as a renal tubular effect biomarker. The BMD studies were performed using BMD software. The benchmark response (BMR) was defined as a 10% additional risk above the background.
There was a positive correlation between the UCd levels and the prevalence of Uβ2-MG. The BMD of UCd for Uβ2-MG was estimated for each province. The findings showed that the BMD levels were related to the participants' geographic region, which may be partially due to the large differences in Cd exposure level, ethnic group, lifestyle and diet of the sample population in these study areas. The reference level of UCd for the renal effects was further evaluated by combining the five sets of data from all 6103 subjects. The overall BMDLs of UCd for Uβ2-MG with an excess risk of 10% were 2.00 μg/g creatinine (μg/g cr) in males and 1.69 μg/g cr in females, which were significantly lower than the World Health Organization (WHO) threshold level of 5 μg/g cr for Cd-related renal effects.
The selection of the sample population and geographic region affected the BMDL evaluation. Based on the findings of this survey of a large sample population, the UCd BMDLs for Uβ2-MG in males with BMRs at 10% were 2.00 μg/g cr. The BMD was slightly lower in females, which indicated that females may be relatively more sensitive to Cd exposure than males.
痛痛病主要由镉(Cd)暴露引起,是日本四大公害病之一。中国一些地区的镉污染比日本更严重。然而,关于中国普通人群镉暴露对健康产生不良影响的阈值水平,目前仍缺乏相关信息。本研究旨在通过大规模抽样调查,评估中国人群中尿镉(UCd)对肾功能障碍的参考值,即基准剂量下限(BMDL)。
共有6103名居住在中国五个镉污染地区的参与者参加了本研究。我们分析了UCd水平作为暴露生物标志物,以及尿β2-微球蛋白(Uβ2-MG)水平作为肾小管效应生物标志物。使用BMD软件进行基准剂量(BMD)研究。基准反应(BMR)定义为高于背景值10%的额外风险。
UCd水平与Uβ2-MG的患病率呈正相关。对每个省份估算了Uβ2-MG的UCd基准剂量。研究结果表明,基准剂量水平与参与者的地理区域有关,这可能部分归因于这些研究地区样本人群的镉暴露水平、种族、生活方式和饮食存在较大差异。通过合并所有6103名受试者的五组数据,进一步评估了UCd对肾脏效应的参考水平。Uβ2-MG的UCd总体基准剂量下限,在男性中为2.00μg/g肌酐(μg/g cr),在女性中为1.69μg/g cr,显著低于世界卫生组织(WHO)规定的与镉相关肾脏效应的5μg/g cr阈值水平。
样本人群和地理区域的选择影响了基准剂量下限的评估。基于本次对大量样本人群的调查结果,男性中Uβ2-MG的UCd基准剂量下限,在基准反应为10%时为2.00μg/g cr。女性的基准剂量略低,这表明女性可能比男性对镉暴露相对更敏感。